Giredestrant tartrate
Giredestrant tartrate is a potent, orally bioavailable, non-steroidal estrogen receptor (ER) antagonist that induces ER degradation and blocks transcriptional activity. It is a research tool for studying ER-positive cancers, with applications in both in vitro mechanistic studies and in vivo xenograft models of breast tumorigenesis.
Product Specifications
CAS Number
2407529-33-1
Product Name Alternative
Estrogen receptor, Estrogen Receptor, Estrogen Receptor/ERR, Estrogen receptor antagonist 1, EstrogenReceptor, Giredestrant Tartrate, ERR
Field of Research
Metabolism Research
Purity
97.01% (May vary between batches)
Solubility
DMSO:55 mg/mL (81.77 mM)
Smiles
[C@@H] ([C@H] (C (O) =O) O) (C (O) =O) O.C (C (CO) (F) F) N1[C@@H] (C2=C (C=3C (N2) =CC=CC3) C[C@H]1C) C4=C (F) C=C (NC5CN (CCCF) C5) C=C4F
Molecular Formula
C31H37F5N4O7
Molecular Weight
672.64
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Glutamine Synthetase (GLuL) (NM_002065) Human Over-expression Lysate
TPO (Thyroid Peroxidase) (Thyroid Marker) (TPO/3813R), CF740 conjugate, 0.1mg/mL
Cytokeratin 15 (Esophageal Squamous Cell Carcinoma Marker) (KRT15/2957), CF740 conjugate, 0.1mg/mL
